Question

I am a breastfeeding mother and i want to know if it is safe to use NIH 2939? Is NIH 2939 safe for nursing mother and child? Does NIH 2939 extracts into breast milk? Does NIH 2939 has any long term or short term side effects on infants? Can NIH 2939 influence milk supply or can NIH 2939 decrease milk supply in lactating mothers?

NIH 2939 lactation summary

NIH 2939 is safe in breastfeeding
  • DrLact safety Score for NIH 2939 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of NIH 2939 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that NIH 2939 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of NIH 2939 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About NIH 2939 usage in lactation

Drug related to same group of 5-NIH 2939 It is excreted in tiny amounts into breast milk with no reported cases of harm effects except a case of mild gastroenteritis.

Answer by DrLact: About NIH 2939 usage in lactation

Limited information indicates that maternal NIH 2939 therapy produces low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Exclusively breastfed infants should be monitored for rare instances of jaundice, gastrointestinal disturbances, hypokalemia, thrombocytopenia, hemolysis and hypokalemia if this drug is used during lactation.[1]

NIH 2939 Side Effects in Breastfeeding

NIH 2939 was used as part of multi-drug regimens to treat 2 pregnant women with multidrug-resistant tuberculosis throughout pregnancy and postpartum. Their two infants were breastfed (extent and duration not stated). At age 1.8 and 4.6 years, the children were developing normally, except for except for a mild speech delay in one at age 1.8 years, and failure to thrive in the other, possibly due to tuberculosis contracted after birth.[2]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.